Drug Safety Signals and Clinical Trials: How Risks Emerge
Discover how drug safety signals emerge from clinical trials and real-world data. Learn why trials miss rare risks, how regulators detect them, and the future of pharmacovigilance.
Discover how drug safety signals emerge from clinical trials and real-world data. Learn why trials miss rare risks, how regulators detect them, and the future of pharmacovigilance.
Registries and claims data are two critical sources of real-world evidence used to monitor drug safety after approval. They offer complementary strengths-registries provide deep clinical detail, while claims data tracks millions across years. Together, they help regulators catch rare side effects and ensure medicines stay safe in everyday use.